Tonghua Golden-Horse Pharmaceutical to Invest 70 Million Yuan for New Subsidiary

MT Newswires Live11-07

Tonghua Golden-Horse Pharmaceutical Industry (SHE:000766) plans to invest 70 million yuan to establish a new subsidiary.

Guilin Jinma Innovation Investment will focus on investment activities, medical research and experimental development, according to a Friday filing with the Shenzhen bourse.

Shares of the drug company closed 2% lower Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment